cocaine has been researched along with 1-methyl-4-phenylpyridinium in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donovan, DM; Kitayama, S; Markham, L; Shimada, S; Uhl, GR; Xu, H | 1 |
| Cowburn, RF; Glover, V; Hardy, JA; Sandler, M; Willoughby, J | 1 |
| Heikkila, RE; Kindt, MV; Mayer, RA | 1 |
| Gu, H; Rudnick, G; Wall, SC | 1 |
| Giovanni, A; Heikkila, RE; Sieber, BA; Sonsalla, PK | 1 |
| Giovanni, A; Heikkila, RE; Sonsalla, PK | 1 |
| Dohi, T; Kitayama, S; Morita, K | 1 |
| Koh, JK; Lee, SH; Lee, YS; Rhee, J | 1 |
| Davis, SC; Dohi, T; Kitayama, S; Morita, K; Uhl, GR; Wang, JB | 1 |
| Gonda, T; Idzu, T; Kimura, K; Kobayashi, Y; Matsubara, K; Okunishi, H | 1 |
| Cho, HK; Lee, SH; Lee, YS; Son, H | 1 |
| Dohi, T; Kitayama, S; Mitsuhata, C; Morita, K; Uhl, GR; Vandenbergh, D | 1 |
| Kang, SS; Lee, SH; Lee, YS; Son, H | 1 |
| Eshleman, AJ; Janowsky, A; Johnson, RA; Meyers, T; Neve, KA | 1 |
| Davis, S; Dohi, T; Kitayama, S; Mitsuhata, C; Morita, K; Sato, T; Uhl, GR; Wang, JB | 1 |
| German, DC; Hogan, KA; Liang, CL; Sonsalla, PK; Staal, RG | 1 |
| McGeer, EG; Stoessl, AJ; Van Kampen, JM | 1 |
| Besnard, J; Chalon, S; Garreau, L; Guilloteau, D; Kodas, E; Zimmer, L | 1 |
| Bryan-Lluka, LJ; Paczkowski, FA | 1 |
| Dohi, T; Kitayama, S; Kozai, K; Kumagai, K; Lin, Z; Mitsuhata, C; Morioka, N; Morita, K; Uhl, GR | 1 |
| Chen, N; Reith, ME | 1 |
| Gai, Y; Guo, LH; Jiang, ZH; Qin, GW; Zhao, G; Zheng, XW | 1 |
| Ananthan, S; Baumann, MH; Moukha-Chafiq, O; Partilla, JS; Pathak, V; Rothman, RB; Saini, SK | 1 |
2 review(s) available for cocaine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding Sites; Carrier Proteins; Cocaine; COS Cells; Dopamine; Dopamine Plasma Membrane Transport Proteins; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Recombinant Proteins | 1996 |
Regulation of dopamine and MPP+ transport by catecholamine transporters.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Cocaine; Dopamine; Drug Design; Humans; Membrane Transport Proteins; Nicotine | 2004 |
21 other study(ies) available for cocaine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Sequence; Animals; Binding, Competitive; Biological Transport; Carrier Proteins; Cell Line; Cell Membrane; Cocaine; DNA; Dopamine; Dopamine Plasma Membrane Transport Proteins; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Models, Structural; Molecular Sequence Data; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Protein Conformation; Transfection | 1992 |
1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cocaine; Corpus Striatum; Dopamine; Humans; Kinetics; Male; Nalidixic Acid; Naphthyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Synaptosomes | 1989 |
Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Flunarizine; Male; Mice; Nalidixic Acid; Naphthyridines; Piperazines; Pyridines; Pyridinium Compounds; Pyrroles; Rats; Rats, Inbred Strains; Substantia Nigra | 1986 |
Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Topics: 1-Methyl-4-phenylpyridinium; Amphetamines; Biogenic Monoamines; Biological Transport; Carrier Proteins; Cell Membrane; Cells, Cultured; Cloning, Molecular; Cocaine; DNA, Complementary; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical; Substrate Specificity; Symporters; Transfection | 1995 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Guanethidine; Male; Mice; Microdialysis; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neurons; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptosomes | 1994 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dose-Response Relationship, Drug; Guanethidine; Male; Mice; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity | 1994 |
Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats | 1996 |
Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cattle; Cells, Cultured; Cocaine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Narcotics; Nerve Tissue Proteins; Protein Binding; Rats; Species Specificity; Transfection | 1996 |
Differences in dopamine efflux induced by MPP+ and beta-carbolinium in the striatum of conscious rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbolines; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Male; Microdialysis; Rats; Rats, Wistar; Tetrodotoxin | 1996 |
Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding Sites; Biological Transport; Carrier Proteins; Cattle; Cocaine; COS Cells; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Mutagenesis; Nerve Tissue Proteins; Recombinant Fusion Proteins; Transfection | 1997 |
Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Sequence; Animals; Carrier Proteins; Cocaine; COS Cells; Cricetinae; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Rats; Substrate Specificity; Tyrosine | 1998 |
The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Carrier Proteins; Cattle; Cocaine; COS Cells; DNA Primers; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Polymerase Chain Reaction; Protein Conformation; Recombinant Fusion Proteins | 1998 |
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Calcium; Carrier Proteins; Cloning, Molecular; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glioma; Half-Life; Humans; Imipramine; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Rats; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transfection; Tritium | 1998 |
MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Carrier Proteins; Cell Membrane; Cell Survival; Cocaine; COS Cells; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; HeLa Cells; Herbicides; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Tetrazolium Salts; Transfection | 1998 |
In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cocaine; Dopamine Agents; Dopamine Uptake Inhibitors; Indicators and Reagents; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microscopy, Electron; Neostriatum; Neuropeptides; Neurotoxins; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptic Vesicles; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Apomorphine; Autoradiography; Carrier Proteins; Cocaine; Corpus Striatum; Cytoprotection; Dopamine Plasma Membrane Transport Proteins; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Tissue Proteins; Oligonucleotides, Antisense; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Nigra; Tritium | 2000 |
Microdialysis as a tool for in vivo study of dopamine transporter function in rat brains.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbon Radioisotopes; Carrier Proteins; Cocaine; Denervation; Dopamine Plasma Membrane Transport Proteins; Male; Mannitol; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Neostriatum; Nerve Tissue Proteins; Oxidopamine; Radioligand Assay; Rats; Rats, Wistar; Scintillation Counting; Tritium | 2000 |
Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Substitution; Animals; Antidepressive Agents; Cocaine; COS Cells; Humans; Kinetics; Mutagenesis, Site-Directed; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Species Specificity; Symporters | 2002 |
Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Topics: 1-Methyl-4-phenylpyridinium; Binding, Competitive; Cell Line; Cocaine; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Epithelial Cells; Gene Expression Regulation; Humans; Norepinephrine; Radioligand Assay; Serotonin | 2007 |
In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cocaine; Cricetinae; Cricetulus; Dopamine; Dopamine Agents; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Norepinephrine; Parkinson Disease; Phenols; Psoralea; Rats; Rats, Sprague-Dawley; Synaptosomes; Tyrosine 3-Monooxygenase | 2009 |
Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding, Competitive; Caudate Nucleus; Cocaine; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Ligands; Male; Rats; Synaptosomes | 2015 |